BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 29163821)

  • 1. The clinical use of circulating microRNAs as non-invasive diagnostic biomarkers for lung cancers.
    Yang Y; Hu Z; Zhou Y; Zhao G; Lei Y; Li G; Chen S; Chen K; Shen Z; Chen X; Dai P; Huang Y
    Oncotarget; 2017 Oct; 8(52):90197-90214. PubMed ID: 29163821
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating microRNAs as a novel class of diagnostic biomarkers in gastrointestinal tumors detection: a meta-analysis based on 42 articles.
    Wang R; Wen H; Xu Y; Chen Q; Luo Y; Lin Y; Luo Y; Xu A
    PLoS One; 2014; 9(11):e113401. PubMed ID: 25406082
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of circulating microRNAs as novel biomarkers in diagnosing colorectal cancer: a meta-analysis.
    Rokkas T; Kothonas F; Rokka A; Koukoulis G; Symvoulakis E
    Eur J Gastroenterol Hepatol; 2015 Jul; 27(7):819-25. PubMed ID: 25856691
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictive power of circulating miRNAs in detecting colorectal cancer.
    Zeng W; Tu Y; Zhu Y; Wang Z; Li C; Lao L; Wu G
    Tumour Biol; 2015 Apr; 36(4):2559-67. PubMed ID: 25527153
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A panel of circulating miRNAs as diagnostic biomarkers for screening multiple myeloma: a systematic review and meta-analysis.
    Zhang L; Cao D; Tang L; Sun C; Hu Y
    Int J Lab Hematol; 2016 Dec; 38(6):589-599. PubMed ID: 27870469
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of serum miRNAs by nano-quantum dots microarray as diagnostic biomarkers for early detection of non-small cell lung cancer.
    Fan L; Qi H; Teng J; Su B; Chen H; Wang C; Xia Q
    Tumour Biol; 2016 Jun; 37(6):7777-84. PubMed ID: 26695145
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNAs as noninvasive biomarkers in bladder cancer detection: a diagnostic meta-analysis based on qRT-PCR data.
    Xiao S; Wang J; Xiao N
    Int J Biol Markers; 2016 Jul; 31(3):e276-85. PubMed ID: 26954073
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating microRNA-21 as a biomarker for the detection of various carcinomas: an updated meta-analysis based on 36 studies.
    Wu K; Li L; Li S
    Tumour Biol; 2015 Mar; 36(3):1973-81. PubMed ID: 25527152
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating microRNAs as novel biomarkers in the diagnosis of prostate cancer: a systematic review and meta-analysis.
    Yin C; Fang C; Weng H; Yuan C; Wang F
    Int Urol Nephrol; 2016 Jul; 48(7):1087-95. PubMed ID: 27068818
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comprehensive meta-analysis of circulation miRNAs in glioma as potential diagnostic biomarker.
    Ma C; Nguyen HPT; Luwor RB; Stylli SS; Gogos A; Paradiso L; Kaye AH; Morokoff AP
    PLoS One; 2018; 13(2):e0189452. PubMed ID: 29444091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of microRNAs as novel biomarkers for glioma detection: a meta-analysis based on 11 articles.
    Qu S; Guan J; Liu Y
    J Neurol Sci; 2015 Jan; 348(1-2):181-7. PubMed ID: 25510379
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating MicroRNA as Potential Source for Neurodegenerative Diseases Biomarkers.
    Zi Y; Yin Z; Xiao W; Liu X; Gao Z; Jiao L; Deng L
    Mol Neurobiol; 2015 Dec; 52(3):1494-1503. PubMed ID: 25367880
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNAs used as novel biomarkers for detecting cancer metastasis.
    Han C; Yu H; Zhang L; Li X; Feng Y; Xin H
    Tumour Biol; 2015 Mar; 36(3):1755-62. PubMed ID: 25366141
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic significance of microRNAs in sepsis.
    Zheng X; Zhang Y; Lin S; Li Y; Hua Y; Zhou K
    PLoS One; 2023; 18(2):e0279726. PubMed ID: 36812225
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic value of circulating microRNAs as biomarkers for breast cancer: a meta-analysis study.
    Cui Z; Lin D; Song W; Chen M; Li D
    Tumour Biol; 2015 Feb; 36(2):829-39. PubMed ID: 25296735
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-17 family as novel biomarkers for cancer diagnosis: a meta-analysis based on 19 articles.
    Gu R; Huang S; Huang W; Li Y; Liu H; Yang L; Huang Z
    Tumour Biol; 2016 May; 37(5):6403-11. PubMed ID: 26631037
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic significance of circulating miRNAs in systemic lupus erythematosus.
    Zheng X; Zhang Y; Yue P; Liu L; Wang C; Zhou K; Hua Y; Wu G; Li Y
    PLoS One; 2019; 14(6):e0217523. PubMed ID: 31163082
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNAs level as an initial screening method for early-stage lung cancer: a bivariate diagnostic random-effects meta-analysis.
    He WJ; Li WH; Jiang B; Wang YF; Xia YX; Wang L
    Int J Clin Exp Med; 2015; 8(8):12317-26. PubMed ID: 26550141
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating microRNAs as biomarkers for diffuse myocardial fibrosis in patients with hypertrophic cardiomyopathy.
    Fang L; Ellims AH; Moore XL; White DA; Taylor AJ; Chin-Dusting J; Dart AM
    J Transl Med; 2015 Sep; 13():314. PubMed ID: 26404540
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A serum exosomal microRNA panel as a potential biomarker test for gastric cancer.
    Wang N; Wang L; Yang Y; Gong L; Xiao B; Liu X
    Biochem Biophys Res Commun; 2017 Nov; 493(3):1322-1328. PubMed ID: 28986250
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.